The effect of PUVA on Langerhans cells in rat oral epithelium photosensitized with systemic methoxsalen or topical trioxsalen

Photodermatology Photoimmunology and Photomedicine

Volumn 16, Issue 3, 2000, Pages 129-133

  Kuusilehto, Asko ^a,b   Happonen, R P ^a   Peltola, J ^a   Lehtinen, R ^a   Jansen C T ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

ATPase staining; Langerhans cells; Psoralens; PUVA

Indexed keywords

ADENOSINE TRIPHOSPHATASE; METHOXSALEN; TRIOXYSALEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; LANGERHANS CELL; MOUTH MUCOSA; NONHUMAN; PHOTOSENSITIZATION; PHOTOTOXICITY; PRIORITY JOURNAL; PUVA; RAT; ULTRAVIOLET A RADIATION;

EID: 0034080107     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2000.160306.x     Document Type: Article

References (38)

1. Parrish JA. Phototherapy and photochemotherapy of skin diseases. J Invest Dermatol 1981: 77: 167-171.
2. Jansén CT, Lehtinen R, Happonen R-P, Lehtinen A, Söderlund K. Mouth-PUVA: new treatment for recalcitrant oral lichen planus. Photodermatol 1987: 4: 165-166.
3. Narwutsch M, Dietz H, Schulz S, Narwutsch M. PUVA therapie bei Lichen ruber oralis. Eine klinisch histologische Studie. Dermatol Mon Schr 1988: 177: 28-38.
4. Narwutsch M, Narwutsch M, Dietz H. Erste Ergebnisse zum Langzeiteffekt des PUVA-therapierten Lichen ruber oralis. Dermatol Mon Schr 1990: 176: 349-355.
5. Lehtinen R, Happonen R-P, Kuusilehto A, Jansén ,C. A clinical trial of PUVA treatment in oral lichen planus. Proc Finn Dent Soc 1989: 85: 29-33.
6. Lundquist G, Forsgren H, Gajecki M, Emtestam L. Photochemotherapy of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995: 79: 554-558.
7. Seoane J, Vázquez J, Romero MA, Aguado A, Pomareda M. Fotoquimioterapia en el tratamiento del liquen erosivo oral. Acta Otorrinolaring Esp 1997: 48: 251-253.
8. Kuusilehto A, Lehtinen R, Happonen R-P, Heikinheimo K, Lehtimäki K, Jansén CT. A clinical open trial of a new mouth-PUVA variant in the treatment of oral lichenoid lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997: 84: 502-505.
9. Lauharanta J, Juvakoski T, Kanerva L, Lassus A. Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid. Arch Dermatol Res 1982: 273: 111-114.
10. Hannuksela M, Kokkonen E-L. Short contact trioxsalen cream PUVA. Photodermatol 1985: 2: 398-400.
11. Koulu L, Jansén CT. Skin phototoxicity variations during repeteated bath PUVA exposures to 8-methoxypsoralen and trimethylpsoralen. Clin Exp Dermatol 1984: 9: 64-69.
12. Lafond G, Roy P-E, Grenier R. Lens opacities appearing during therapy with methoxsalen and long wave-length ultraviolet radiation. Can J Ophthalmol 1984: 19: 173-175.
13. Lerman S. Ocular side effects of psoriasis therapy. N Engl J Med 1980: 303: 941-942.
14. Dunnick JK, Davis WE, Jorgenson TA, Rosen VJ, McConnell EE. Subchronic toxicity in rats administered oral 8-methoxypsoralen. Natl Cancer Inst Monogr 1984: 66: 91-95.
15. Bridges BA. Psoralens and serendipity: aspects of the genetic toxicology of 8-methoxypsoralen. Environ Mutagen 1983: 5: 329-339.
16. Hannuksela M, Senbäck F, Lahti A. The carcinogenic properties of topical PUVA. A lifelong study on mice. Arch Dermatol Res 1986: 278: 347-351.
17. Lindelöf B, Sigurgeirsson B, Tegner E, Larkö O, Berne B. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. Arch Dermatol 1992: 128: 1341-1344.
18. Hannuksela A, Pukkala E, Hannuksela M, Karvonen J. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA. J Am Acad Dermatol 1996: 35 (5 Pt 1): 685-686.
19. Cruz PD, Bergstresser PR. The influence of ultraviolet radiation and other chemical agents on epidermal Langerhans cells. In: Schuler G, ed. Epidermal Langerhans cells. Boca Raton: CRC Press Inc., 1991: 253-271.
20. Koulu L, Jansén CT. In vivo PUVA sensitivity of various human epidermal Langerhans cell markers (ATPase, HLA-DR and T6). Dose response and time sequence studies. Clin Exp Dermatol 1988: 13: 173-176.
21. Juhlin L, Shelley WB. New staining techniques for the Langerhans cell. Acta Derm Venereol (Stockh) 1977: 57: 289-296.
22. Juhlin L, Shelley WB. Giant Langerhans cells induced by psoralen and ultraviolet radiation. Arch Dermatol Res 1979: 266: 311-314.
23. Daniels TE. Human mucosal Langerhans cells: postmortem identification of regional variations in oral mucosa. J Invest Dermatol 1984: 82: 21-24.
24. Ahlfors EE, Larsson PÅ, Bergstresser PR. Langerhans cell surface densities in rat oral mucosa and human buccal mucosa. J Oral Pathol 1985: 14: 390-397.
25. Mitsudo K, Kobayashi M, Tohnai I, Ueda M, Kotani H, Hoshino T. Electron microscopic and immunohistochemical studies of Langerhans cells and Thy-1-positive cells in mouse tongue epithelium subjected to local hyperthermia. Arch Oral Biol 1995: 40: 533-538.
26. Young AR. The sunburn cell. Photodermatology 1987: 4: 127-134.
27. Kuusilehto A, Lehtinen R, Jansén CT. Comparison of the minimal phototoxic dose in topical 4,5',8-trimethylpsoralen PUVA treatment of caucasian skin and of oral mucous membrane. Acta Derm Venereol (Stockh) 1990: 70: 508-509.
28. Smyth RD, van Harken DR, Pfeffer M et al. Biological disposition of 8-methoxsalen in rat and man. Arzneim Forsch/Drug Res 1980: 30(II): 1725-1730.
29. Engel RF, Wulf HC. Localisation of radioactivity in rat organs after oral administration of tritiated 8-methoxypsoralen in therapeutic doses. Arch Dermatol Res 1982: 273: 71-84.
30. Roelandts R, van Boven M, Adriaens P, de Schryver F, Degreef H. The relationship between 8-methoxypsoralen skin and blood levels. J Invest Dermatol 1983: 81: 331-333.
31. van Boven M, Adriaens P, Roelandts R, Daenens P. Skin determination of the 8-methoxypsoralen concentration in rats. Photodermatol 1984: 1: 241-244.
32. Mays DC, Rogers SL, Guiler RC et al. Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites. J Pharmacol Exp Ther 1986: 236: 364-373.
33. Barrett AW, Cruchley AT, Williams DM. Oral mucosal Langerhans' cells. Crit Rev Oral Biol Med 1996: 7: 36-58.
34. Lombardi T, Hauser C, Budtz-Jörgensen E. Langerhans cells: Structure function and role in oral pathological conditions. J Oral Pathol Med 1993: 22: 193-202.
35. Sauget P, Soubiran P, Monteil RA. Physiologie des cellules de Langerhans et rôle potentiel en pathologie orale. Jour Biol Buccale: 1986: 14: 3-14.
36. Fuchs C, Asen S, Panhans-Gross A, Bieber T. Are CD1A+/HLA-DR+ dendritic cells of the oral mucosa Langerhans cells? In: Abstracts for International Investigative Dermatology, Cologne, Germany, May 7-10, 1998. J Invest Dermatol 1998: 110: 980.
37. van Wilsem EJG, van Hoogstraten IMW, Brevé J, Scheper RJ, Kraal G. Dendritic cells of the oral mucosa and the induction of tolerance. A local affair. Immunology 1994: 83: 128-132.
38. van Wilsem EJG, Brevé J, Savelkoul H, Claessen A, Scheper RJ, Kraal G. Oral tolerance is determined at the level of draining lymph nodes. Immunobiol 1995: 194: 403-414.